Source: EMaxHealth.com

Date: 03/13/06

Headline: Early results using therapeutic pancreatic cancer vaccine show promise

Johns Hopkins Kimmel Cancer Center researchers are encouraged by early results of a treatment vaccine for pancreatic cancer, a disease with few options and low odds for long-term survival. At about two years into a study of 60 patients, the researchers report that 88 percent survived one year and 76 percent are alive after two years.